BLRX
BioLineRx LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$15.61M
P/E Ratio
0.00
EPS
$0.00
Beta
0.62
52W High
$5.06
52W Low
$2.15
50-Day MA
$2.83
200-Day MA
$3.14
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
93.46
PEG Ratio
0.20
About BioLineRx Ltd
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company is headquartered in Hevel Modi'in, Israel.
Fundamentals
| Revenue (TTM) | $1.40M |
| Gross Profit (TTM) | $1.11M |
| EBITDA | $-10.75M |
| Operating Margin | -630.00% |
| Return on Equity | -46.70% |
| Return on Assets | -16.60% |
| Revenue/Share (TTM) | $0.60 |
| Book Value | $3.60 |
| Price-to-Book | 0.91 |
| Price-to-Sales (TTM) | 11.14 |
| EV/Revenue | 3.499 |
| EV/EBITDA | 0.01 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 87.10% |
| Shares Outstanding | $4.35M |
| Float | $4.16M |
| % Insiders | 3.98% |
| % Institutions | 0.45% |
Historical Volatility
HV 10-Day
62.87%
HV 20-Day
75.88%
HV 30-Day
76.03%
HV 60-Day
83.94%
HV Rank
75.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($17.50 target)
1
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026